Literature DB >> 27063970

Hope for BET inhibition in patients with leukaemia or lymphoma.

Mohamed A Kharfan-Dabaja1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27063970     DOI: 10.1016/S2352-3026(15)00253-7

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN: 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  1 in total

1.  Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.

Authors:  Neel Shah; Ping Wang; John Wongvipat; Wouter R Karthaus; Wassim Abida; Joshua Armenia; Shira Rockowitz; Yotam Drier; Bradley E Bernstein; Henry W Long; Matthew L Freedman; Vivek K Arora; Deyou Zheng; Charles L Sawyers
Journal:  Elife       Date:  2017-09-11       Impact factor: 8.140

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.